Cargando…
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
The PI3K/AKT/mTOR (PAM) signaling pathway is a highly conserved signal transduction network in eukaryotic cells that promotes cell survival, cell growth, and cell cycle progression. Growth factor signalling to transcription factors in the PAM axis is highly regulated by multiple cross-interactions w...
Autores principales: | Glaviano, Antonino, Foo, Aaron S. C., Lam, Hiu Y., Yap, Kenneth C. H., Jacot, William, Jones, Robert H., Eng, Huiyan, Nair, Madhumathy G., Makvandi, Pooyan, Geoerger, Birgit, Kulke, Matthew H., Baird, Richard D., Prabhu, Jyothi S., Carbone, Daniela, Pecoraro, Camilla, Teh, Daniel B. L., Sethi, Gautam, Cavalieri, Vincenzo, Lin, Kevin H., Javidi-Sharifi, Nathalie R., Toska, Eneda, Davids, Matthew S., Brown, Jennifer R., Diana, Patrizia, Stebbing, Justin, Fruman, David A., Kumar, Alan P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436543/ https://www.ncbi.nlm.nih.gov/pubmed/37596643 http://dx.doi.org/10.1186/s12943-023-01827-6 |
Ejemplares similares
-
Chromatin regulation at the intersection of estrogen receptor and PI3K pathways in breast cancer
por: Castel, Pau, et al.
Publicado: (2019) -
Epigenetic Mechanisms Influencing Therapeutic Response in Breast Cancer
por: Arruabarrena-Aristorena, Amaia, et al.
Publicado: (2022) -
Chitosan nanofiber biocomposites for potential wound healing applications: Antioxidant activity with synergic antibacterial effect
por: Bagheri, Mitra, et al.
Publicado: (2021) -
The present and future of PI3K inhibitors for cancer therapy
por: Castel, Pau, et al.
Publicado: (2021) -
Pancancer modelling predicts the context-specific impact of somatic mutations on transcriptional programs
por: Osmanbeyoglu, Hatice U., et al.
Publicado: (2017)